Tissue Regenix Group (LSE:TRX) Total Stockholders Equity : £23.82 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Total Stockholders Equity?

Tissue Regenix Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £23.82 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Tissue Regenix Group's Book Value per Share for the quarter that ended in Dec. 2023 was £0.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Tissue Regenix Group's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.31.

Tissue Regenix Group Total Stockholders Equity Historical Data

The historical data trend for Tissue Regenix Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Total Stockholders Equity Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

25.22

29.04

25.83

25.66

23.82

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															25.83	25.95	25.66	24.28	23.82

Tissue Regenix Group (LSE:TRX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Tissue Regenix Group's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(23.819	-	0)	/	70.5745
	=	0.34

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Tissue Regenix Group's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.507	+	6.915)	/	23.819
	=	0.31

Tissue Regenix Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.